Nanomedicine and Nanoscale Delivery (Focus Group – NND)
Citlaly Bucio Arzate, MSC. (she/her/hers)
Master of Science
Universidad Autonoma de Baja California
Tijuana, Baja California, Mexico
Cancer has the highest prevalence and death rate in the world. It is estimated that an additional one million new cancer cases will be diagnosed in Latin America by 2040 [1]. Although chemotherapy is the most efficient treatment for this disease, it is limited by its cytotoxicity. Recent advances in anti-cancer therapies have led to the development of treatments based on drug delivery systems like nanoparticles attached to ligands capable of recognizing tumor cells have been used as vehicles for this purpose. This work aims to synthesize gelatin nanoparticles coupled to green fluorescent protein (GFP). This will serve as a probe concept for coupling proteins as recognition elements to cancer cells.